Molecular formula: | C63H98N18O13S |
Average mass: | 1347.650 |
Monoisotopic mass: | 1346.728146 |
ChemSpider ID: | 33558 |
10 of 10 defined stereocentres
Wikipedia
12769-48-1
[RN]33507-63-0
[RN]675VGV5J1D
[UNII]L-Methioninamide, N~5~-(diaminomethylene)-L-ornithyl-L-prolyl-L-lysyl-L-prolyl-L-glutaminyl-L-glutaminyl-L-phenylalanyl-L-phenylalanylglycyl-L-leucyl-
[ACD/Index Name]N~5~-(Diaminomethylen)-L-ornithyl-L-prolyl-L-lysyl-L-prolyl-L-glutaminyl-L-glutaminyl-L-phenylalanyl-L-phenylalanylglycyl-L-leucyl-L-methioninamid
[German]
[ACD/IUPAC Name]N~5~-(Diaminomethylene)-L-ornithyl-L-prolyl-L-lysyl-L-prolyl-L-glutaminyl-L-glutaminyl-L-phenylalanyl-L-phenylalanylglycyl-L-leucyl-L-methioninamide
[ACD/IUPAC Name]N~5~-(Diaminométhylène)-L-ornithyl-L-prolyl-L-lysyl-L-prolyl-L-glutaminyl-L-glutaminyl-L-phénylalanyl-L-phénylalanylglycyl-L-leucyl-L-méthioninamide
[French]
[ACD/IUPAC Name]Substance P
[Wiki](2S)-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-1-[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-N-[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-amino-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1,5-dioxopentan-2-yl]pentanediamide
(2S)-2-{[(2S)-1-[(2S)-6-amino-2-{[(2S)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}hexanoyl]pyrrolidin-2-yl]formamido}-N-[(1S)-3-carbamoyl-1-{[(1S)-1-{[(1S)-1-[({[(1S)-1-{[(1S)-1-carbamoyl-3-(methylsulfanyl)propyl]carbamoyl}-3-methylbutyl]carbamoyl}methyl)carbamoyl]-2-phenylethyl]carbamoyl}-2-phenylethyl]carbamoyl}propyl]pentanediamide
(SP)Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2
11035-08-8
[RN]148465-45-6
[RN]148470-19-3
[RN]251-545-8
[EINECS]71977-09-8
[RN][³H]SP (human, mouse, rat)
[¹²⁵I]SP (human, mouse, rat)
Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met NH2(Substance P) SP
Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-amine
Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2
ARG-PRO-LYS-PRO-GLN-GLN-PHE-PHE-GLY-LEU-MET-NH2 3ACOH 5H2O
Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2(Substance P)
Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2.(Substance P)
ArgProLysProGlnGlnPhePheGlyLeuMet
ATP synthase subunit a
ATP6_RAT
BHE22_MOUSE
Eledoisin
GHSR_HUMAN
H-Arg-Pro-Lys-Pro-Gln-Gln-Phe-D-Phe-Gly-Leu-Met-NH2
H-Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2
H-Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2(Substance P)
L-Arg-L-Pro-L-Lys-L-Pro-L-Gln-L-Gln-L-Phe-L-Phe-Gly-L-Leu-L-Met-NH2
MFCD00076780
[MDL number]MRGX2_HUMAN
Neuromedin-K receptor
NK1R_CAVPO
NK1R_HUMAN
NK1R_RAT
NK2R_CAVPO
NK2R_HUMAN
NK3R_HUMAN
Prothrombin
P物質
[Japanese]RPKPQQFFGLM-amide
RPKPQQFFGLM-NH2
SP
Substance P (Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-MetNH2)
Substance-K receptor
Substance-P receptor
Substanz-P
tachykinin substance P (SP)
THRB_HUMAN
TKN1_HUMAN
TKN1_MOUSE
TKN1_RAT
TKN_ELEMO
TKNA_CAVPO